U.S. Army scientists have launched a phase 1 clinical trial of an experimental vaccine against the Middle East respiratory syndrome coronavirus, DoD News reported Feb. 17. Cheryl Pellerin writes researchers at the
We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them on our Privacy Policy. If you continue to use this site, you consent to our use of cookies.